These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
5. In vitro and in vivo production of interleukin-6 induced by muramyl peptides and lipopolysaccharide in normal dogs. Shi F, Kurzman ID, MacEwen EG. Cancer Biother; 1995 Jul; 10(4):317-25. PubMed ID: 8590897 [Abstract] [Full Text] [Related]
8. The pyrogenicity of the synthetic adjuvant muramyl dipeptide and two structural analogues. Dinarello CA, Elin RJ, Chedid L, Wolff SM. J Infect Dis; 1978 Dec 10; 138(6):760-7. PubMed ID: 368262 [Abstract] [Full Text] [Related]
9. Biotransformation of drugs in rats treated with a synthetic muramyl dipeptide, N-acetylmuramyl-L-alanyl-D-isoglutamine (MDP). Zídek Z, Kameníková L, Buchar E, Janků I, Masek K. Int J Immunopharmacol; 1983 Dec 10; 5(2):151-5. PubMed ID: 6874168 [Abstract] [Full Text] [Related]
14. N-acetyl muramyl dipeptide stimulation of bone resorption in tissue culture. Dewhirst FE. Infect Immun; 1982 Jan 10; 35(1):133-7. PubMed ID: 7054120 [Abstract] [Full Text] [Related]
15. Muramyl dipeptide-induced sleep and fever: effects of ambient temperature and time of injections. Shoham S, Krueger JM. Am J Physiol; 1988 Jul 10; 255(1 Pt 2):R157-65. PubMed ID: 3394839 [Abstract] [Full Text] [Related]
17. A novel immunostimulator, N-[alpha-O-benzyl-N-(acetylmuramyl)-L-alanyl-D-isoglutaminyl]-N6-trans-(m-nitrocinnamoyl)-L-lysine, and its adjuvancy on the hepatitis B surface antigen. Yang HZ, Xu S, Liao XY, Zhang SD, Liang ZL, Liu BH, Bai JY, Jiang C, Ding J, Cheng GF, Liu G. J Med Chem; 2005 Aug 11; 48(16):5112-22. PubMed ID: 16078831 [Abstract] [Full Text] [Related]